Outcomes of allogeneic stem cell transplantation in elderly patients

Описание к видео Outcomes of allogeneic stem cell transplantation in elderly patients

Yngvar Floisand, MD, PhD, Oslo University Hospital, Oslo, Norway, discusses outcomes associated with allogeneic stem cell transplantation in elderly patients (65 years or above) with acute myeloid leukemia or myelodysplastic syndrome, the findings of which support the use of this treatment approach in elderly patients. This interview took place during the Transplantation & Cellular Therapy (TCT) 2021 Meetings.

Комментарии

Информация по комментариям в разработке